AC Immune SA (ACIU)
2.11
-0.15
(-6.64%)
USD |
NASDAQ |
Jun 10, 16:00
2.11
0.00 (0.00%)
After-Hours: 18:50
AC Immune 1 Year Total Returns (Daily) : 7.62% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 7.62% |
| June 08, 2026 | 7.35% |
| June 05, 2026 | 30.06% |
| June 04, 2026 | 43.71% |
| June 03, 2026 | 44.85% |
| June 02, 2026 | 47.11% |
| June 01, 2026 | 43.86% |
| May 29, 2026 | 56.93% |
| May 28, 2026 | 63.69% |
| May 27, 2026 | 73.37% |
| May 26, 2026 | 73.37% |
| May 22, 2026 | 66.96% |
| May 21, 2026 | 72.73% |
| May 20, 2026 | 65.14% |
| May 19, 2026 | 62.07% |
| May 18, 2026 | 61.99% |
| May 15, 2026 | 77.71% |
| May 14, 2026 | 83.01% |
| May 13, 2026 | 80.89% |
| May 12, 2026 | 69.94% |
| May 11, 2026 | 68.45% |
| May 08, 2026 | 72.29% |
| May 07, 2026 | 75.90% |
| May 06, 2026 | 83.33% |
| May 05, 2026 | 76.02% |
| Date | Value |
|---|---|
| May 04, 2026 | 77.33% |
| May 01, 2026 | 78.44% |
| April 30, 2026 | 75.14% |
| April 29, 2026 | 72.35% |
| April 28, 2026 | 78.24% |
| April 27, 2026 | 73.17% |
| April 24, 2026 | 71.08% |
| April 23, 2026 | 87.97% |
| April 22, 2026 | 104.0% |
| April 21, 2026 | 93.92% |
| April 20, 2026 | 101.4% |
| April 17, 2026 | 103.4% |
| April 16, 2026 | 104.7% |
| April 15, 2026 | 107.9% |
| April 14, 2026 | 109.9% |
| April 13, 2026 | 111.5% |
| April 10, 2026 | 121.6% |
| April 09, 2026 | 122.2% |
| April 08, 2026 | 112.6% |
| April 07, 2026 | 95.60% |
| April 06, 2026 | 62.65% |
| April 02, 2026 | 46.81% |
| April 01, 2026 | 55.43% |
| March 31, 2026 | 47.06% |
| March 30, 2026 | 29.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| BeOne Medicines Ltd. | 1.66% |
| CRISPR Therapeutics AG | 22.31% |
| Idorsia Ltd. | 209.1% |
| ADC Therapeutics SA | -69.19% |
| MoonLake Immunotherapeutics | -61.82% |